PATIENT-CENTRIC PACKAGE FOR SPECIALTY PHARMA
inVentiv Health announced Embarx, a customizable, patient-centric offering designed for specialty biotech and pharmaceutical products. Embarx includes services such as strategic consulting, reimbursement support, clinical nursing teams, adherence programs, REMS, payer communications, and field team support.
iCONNECT iPAD SUITE
Klick Health launched iConnect, a suite of “software-as-a-service” iOS apps for pharmaceutical sales reps. The apps include tools for marketing, operations, and training. iConnect embraces presentation tools, CRM integration and call-planning, a learning portal, plan-of-action support, document management, and electronic forms.
PROXIMIC, PRECISION HEALTH PARTNER
Precision Health Media (PHM) has teamed with Proximic, an innovator of accurate page-level data services. The partnership augments PHM’s Condition Match technology, providing more targeted and brand-safe ad delivery for pharmaceutical and health brands to consumers engaged in seeking specific content about physician-diagnosed conditions. Condition Match helps advertisers to zero in precisely on patients with one or more existing medical conditions.
“WHAT PHYSICIANS WANT”
Publicis Touchpoint Solutions released the third edition of their What Physicians Want! survey. This survey updates two previous reports (published in 2008 and 2010) to demonstrate how well the life sciences industry is fulfilling its value proposition to physicians. From this report, it is clear that physicians’ attention is on health outcomes and finding new ways to support and educate patients. A new white paper containing the complete survey results is available for complimentary download from the company’s website (see bit.ly/HqetOS).
SUPREME COURT BACKS GENERICS, PAY-TO-DELAY
The U.S. Supreme Court sided with generic drug makers, deciding (in Caraco Pharmaceutical Laboratories v. Novo Nordisk) that generics makers can sue the brand-name innovator, forcing the innovator to correct FDA-filed data the agency uses in approving generic ANDAs. The decision (reversing a lower court finding) says that generics makers may employ Hatch-Waxman Act counterclaim provisions to correct errors in the original coding of the brand’s patent. In another decision, the court refused to consider a Federal Trade Commission-backed challenge (brought by Louisiana Wholesale Drug, in conjunction with CVS and Rite Aid) to a pay-to-delay arrangement for Cipro, between Bayer and generic-maker Barr Laboratories.
GLOBAL GENERICS MARKET GROWS TO $221 BILLION
BY 2016 According to a new Espicom analysis, The World Generic Market Report, global markets for generic drugs will continue to grow despite cost containment pressures from health payers in many markets. The worldwide market will reach $221 billion, and the U.S. market will rise to $104.1 billion.
EUROPEAN AUSTERITY BOOSTS GENERICS
Generic drugs are expected to help countries cope with healthcare cuts brought about by strict austerity measures, according to a new report by business intelligence experts GBI Research. A new report suggests that lower priced generic drugs help control costs, saving patients, drug manufacturers, retailers and the government a considerable amount of money. Price cuts have also proven to be an effective tool in limiting pharmaceutical expenditure and budget deficits.
LINKING DOCTORS ON THE GO
DocBookMD allows doctors to send and receive secure HIPAA compliant patient information right from an iPhone or iPad. The app is free for physicians who are members of their county or state medical societies. All activity is run through a secure server, with multiple encryption levels, and the data is stored on the server, not the physician’s mobile device.
HLG HEALTH COMMUNICATIONS
The Hal Lewis Group is changing its name to HLG Health Communications. Over the past 30 years, the agency has become best known to its clients and peers by its initials, making this a natural transition. The agency specializes in mid-size pharmaceutical companies and provides several solutions options.
FLAUM NAVIGATORS LAUNCHES
Sander A. Flaum announces the launch of Flaum Navigators, focused on the multi-dynamics of business growth. Flaum Navigators will work with pharma leaders on new ways to galvanize brand growth through C-Suite consulting, leadership and innovation workshops. The company’s eponymous principal, Sander Flaum, said, “We will assist corporate and marketing colleagues on resurrecting products, creating disruptive innovations, turning sales effectiveness programs into authentic sales generation and delivering leadership workshops for seasoned executives.” —Johnathan Lugo
